S&P 500   3,114.03 (+0.04%)
DOW   27,660.11 (+0.04%)
QQQ   202.53 (+0.05%)
FB   198.79 (+0.04%)
MSFT   149.80 (-0.03%)
AMZN   1,744.90 (-0.90%)
NVDA   208.90 (-0.25%)
MU   46.45 (+0.32%)
TSLA   331.38 (-0.50%)
PRI   134.97 (+1.34%)
DIS   148.22 (-0.04%)
S&P 500   3,114.03 (+0.04%)
DOW   27,660.11 (+0.04%)
QQQ   202.53 (+0.05%)
FB   198.79 (+0.04%)
MSFT   149.80 (-0.03%)
AMZN   1,744.90 (-0.90%)
NVDA   208.90 (-0.25%)
MU   46.45 (+0.32%)
TSLA   331.38 (-0.50%)
PRI   134.97 (+1.34%)
DIS   148.22 (-0.04%)
S&P 500   3,114.03 (+0.04%)
DOW   27,660.11 (+0.04%)
QQQ   202.53 (+0.05%)
FB   198.79 (+0.04%)
MSFT   149.80 (-0.03%)
AMZN   1,744.90 (-0.90%)
NVDA   208.90 (-0.25%)
MU   46.45 (+0.32%)
TSLA   331.38 (-0.50%)
PRI   134.97 (+1.34%)
DIS   148.22 (-0.04%)
S&P 500   3,114.03 (+0.04%)
DOW   27,660.11 (+0.04%)
QQQ   202.53 (+0.05%)
FB   198.79 (+0.04%)
MSFT   149.80 (-0.03%)
AMZN   1,744.90 (-0.90%)
NVDA   208.90 (-0.25%)
MU   46.45 (+0.32%)
TSLA   331.38 (-0.50%)
PRI   134.97 (+1.34%)
DIS   148.22 (-0.04%)
Log in

LON:AZN - AstraZeneca Share Price, Forecast & News

GBX 7,229
-84.00 (-1.15 %)
(As of 12/5/2019 01:49 PM ET)
Today's Range
7,221
Now: GBX 7,229
7,353
50-Day Range
6,729
MA: GBX 7,282.98
7,580
52-Week Range
109.51
Now: GBX 7,229
8,227.88
Volume1.44 million shs
Average Volume2.31 million shs
Market Capitalization£94.84 billion
P/E Ratio45.35
Dividend Yield2.90%
BetaN/A
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-73045000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£24.14 billion
Cash FlowGBX 348.35 per share
Book ValueGBX 927.10 per share

Profitability

Miscellaneous

Employees64,400
Outstanding Shares1,311,900,032
Market Cap£94.84 billion
Next Earnings Date2/14/2020 (Estimated)
OptionableOptionable

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.


AstraZeneca (LON:AZN) Frequently Asked Questions

What is AstraZeneca's stock symbol?

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a dividend on Thursday, July 25th. Investors of record on Thursday, August 8th will be paid a dividend of GBX 71.90 per share on Monday, September 9th. This represents a yield of 1.07%. The ex-dividend date is Thursday, August 8th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release their next quarterly earnings announcement on Friday, February 14th 2020. View Earnings Estimates for AstraZeneca.

What price target have analysts set for AZN?

16 brokers have issued 12-month price objectives for AstraZeneca's shares. Their forecasts range from GBX 5,500 to £100. On average, they anticipate AstraZeneca's share price to reach GBX 7,585.67 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price. View Analyst Price Targets for AstraZeneca.

What is the consensus analysts' recommendation for AstraZeneca?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Has AstraZeneca been receiving favorable news coverage?

Press coverage about AZN stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AstraZeneca earned a news impact score of 0.9 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for AstraZeneca.

Who are some of AstraZeneca's key competitors?

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Hain Celestial Group (HAIN), Vodafone Group (VOD), National Retail Properties (NNN), NVIDIA (NVDA), BP (BP), Marks and Spencer Group (MKS), Royal Dutch Shell (RDSB), Encana (ECA) and Philip Morris International (PM).

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the folowing people:
  • Mr. Pascal Soriot, CEO & Exec. Director (Age 60)
  • Mr. Marc Dunoyer, CFO & Exec. Director (Age 67)
  • Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 48)
  • Thomas Kudsk Larsen, Head of Investor Relations
  • Mr. Jefrey Pott, Gen. Counsel

How do I buy shares of AstraZeneca?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately GBX 7,229.

How big of a company is AstraZeneca?

AstraZeneca has a market capitalization of £94.84 billion and generates £24.14 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

What is AstraZeneca's official website?

The official website for AstraZeneca is http://www.astrazeneca.com/.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.


MarketBeat Community Rating for AstraZeneca (LON AZN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  1,487 (Vote Outperform)
Underperform Votes:  1,672 (Vote Underperform)
Total Votes:  3,159
MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote "Outperform" if you believe AZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel